Skip to main content

a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with S

Sickle Screen (Haemoglobin S)

Sickle Screen (Haemoglobin S)

  • Turnaround Time: 4 hours from receipt if urgent
Salicylate

Salicylate

Reference Range

Not applicable (use in overdose only)

  • Turnaround Time: 24 hours

Salivary Cortisol

Reference Range

Early morning range (7-9 a.m.): 3.2-22.8 nmol/L

Late night range (11 p.m. to 12 a.m.): <3.2 nmol/L

  • Turnaround Time: 15 working days (3 weeks)

Salivary Cortisol

Reference Range

Early morning range (7-9 a.m.): 3.2-22.8 nmol/L

Late night range (11 p.m. to 12 a.m.): <3.2 nmol/L

  • Turnaround Time: 15 working days (3 weeks)
SARS-Cov2 IgG Antibodies (Abbott)

SARS-Cov2 IgG Antibodies (Abbott)

Reference Range

Negative -  No evidence of antibody response to SARS-CoV-2. This can indicate
no COVID-19 infection, very early infection, or infection in the
context of immunosupression.
An increase in antibody level can support a diagnosis of Covid-19.
Consider repeat testing in 14 days if confirmation of infection or exposure to COVID 19 is suspected

Any result should not affect compliance with personal
protection guidelines.

Equivocal - SARS-CoV-2 IgG antibodies: Equivocal by EIA (Abbott)
Inconclusive result, which may occur early in the infection or
could be non-specific.
An increase in antibody level can support a diagnosis of Covid-19.
Consider repeat testing in 14 days if confirmation of infection or exposure to COVID 19 is suspected

Any result should not affect compliance with personal
protection guidelines.

Positive - SARS-CoV-2 IgG antibodies: Positive by EIA (Abbott)
Consistent with current or previous Covid-19 infection.
Please Note result DOES NOT indicate immunity from future
infection or prevent current or future excretion of the
virus (infectivity).

Any result should not affect compliance with personal
protection guidelines.

SARS-Cov2 IgG Antibodies (Abbott)

SARS-Cov2 IgG Antibodies (Abbott)

Reference Range

Negative -  No evidence of antibody response to SARS-CoV-2. This can indicate
no COVID-19 infection, very early infection, or infection in the
context of immunosupression.
An increase in antibody level can support a diagnosis of Covid-19.
Consider repeat testing in 14 days if confirmation of infection or exposure to COVID 19 is suspected

Any result should not affect compliance with personal
protection guidelines.

Equivocal - SARS-CoV-2 IgG antibodies: Equivocal by EIA (Abbott)
Inconclusive result, which may occur early in the infection or
could be non-specific.
An increase in antibody level can support a diagnosis of Covid-19.
Consider repeat testing in 14 days if confirmation of infection or exposure to COVID 19 is suspected

Any result should not affect compliance with personal
protection guidelines.

Positive - SARS-CoV-2 IgG antibodies: Positive by EIA (Abbott)
Consistent with current or previous Covid-19 infection.
Please Note result DOES NOT indicate immunity from future
infection or prevent current or future excretion of the
virus (infectivity).

Any result should not affect compliance with personal
protection guidelines.

[12 3 4  >>